Strategies for recruitment and retention of underrepresented populations with chronic obstructive pulmonary disease for a clinical trial.

Beatrice HuangDenise De VoreChris ChirinosJessica WolfDevon LowRachel Willard-GraceStephanie TsaoChris GarveyDoranne DoneskyGeorge SuDavid H Thom

Published in: BMC medical research methodology (2019)

This trial was registered at ClinicalTrial.gov at identifier NCT02234284 on August 12, 2014. Descriptor number: 2.9 Racial, ethnic, or social disparities in lung disease and treatment.

Keyphrases

clinical trial
chronic obstructive pulmonary disease
phase ii
study protocol
phase iii
mental health
open label
randomized controlled trial
double blind
cystic fibrosis
replacement therapy
smoking cessation